Prediction of toxicity using metabolic tumor volume and body composition analysis in patients with advanced stage Hodgkin lymphoma undergoing treatment with BVAVD

被引：0
|
作者：
Kuker, Russ [1 ]
Stanchina, Michele [2 ]
Han, Sunwoo [3 ]
Polar, Mark [4 ]
Uribe, Laura Palacio [5 ]
Crane, Tracy [2 ]
Yang, Fei [3 ]
Moskowitz, Craig [1 ]
Alderuccio, Juan [2 ]
机构：
[1] Univ Miami Miller Sch Med, Miami, FL USA
[2] Sylvester Comprehens Canc Ctr, Miami, FL USA
[3] Univ Miami, Miami, FL USA
[4] Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL USA
[5] Jackson Mem Hosp, Miami, FL USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2024年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
241241
引用
收藏
页数：3
相关论文
共 50 条
  • [21] METABOLIC TUMOR VOLUME BY PET/CT AS A CLINICAL PARAMETER TO DETERMINE THERAPEUTIC MODALITY IN THE EARLY STAGE HODGKIN'S LYMPHOMA.
    Song, M.
    Chung, J.
    Lee, J.
    Moon, J.
    Lee, S.
    Hong, J.
    Lee, S.
    HAEMATOLOGICA, 2013, 98 : 68 - 69
  • [22] INTENSITY-MODULATED RADIOTHERAPY FOR THE TREATMENT OF MEDIASTINAL TUMOR MASSES IN PATIENTS WITH EARLY STAGE HODGKIN LYMPHOMA
    Girinsky, T.
    Ghalibafian, M.
    Ferreira, I.
    Dessard, N.
    Paumier, A.
    Messai, T.
    RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S294 - S294
  • [23] Prognostic value of baseline metabolic tumor volume in early-stage Hodgkin lymphoma in the standard arm of the H10 trial
    Cottereau, Anne-Segolene
    Versari, Annibale
    Loft, Annika
    Casasnovas, Olivier
    Bellei, Monica
    Ricci, Romain
    Bardet, Stephane
    Castagnoli, Antonio
    Brice, Pauline
    Raemaekers, John
    Deau, Benedicte
    Fortpied, Catherine
    Raveloarivahy, Tiana
    Van Zele, Emelie
    Chartier, Loic
    Borght, Thierry Vander
    Federico, Massimo
    Hutchings, Martin
    Ricardi, Umberto
    Andre, Marc
    Meignan, Michel
    BLOOD, 2018, 131 (13) : 1456 - 1463
  • [24] Modification of escalated beacopp with dacarbazine substitution reduces toxicity while maintaining efficacy for the treatment of advanced-stage Hodgkin lymphoma
    Santarsieri, Anna
    Sturgess, Katherine
    Brice, Pauline
    Menne, Tobias F.
    Osborne, Wendy
    Creasey, Thomas
    Ardeshna, Kirit M.
    Behan, Sarah
    Bhuller, Kaljit
    Booth, Stephen
    Collins, Graham P.
    Cwynarski, Kate
    Furtado, Michelle
    Iyengar, Sunil
    Jones, Stephen G.
    O'Mahony, Deidre
    Martinez-Calle, Nicolas
    McKay, Pamela
    Nagumantry, Sateesh K.
    Rudge, John F.
    Shah, Nimish
    Stafford, Gwyneth
    Sternberg, Alexander
    Uttenthal, Benjamin J.
    McMillan, Andrew K.
    Follows, George A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 : 40 - 41
  • [25] Whole-slide image analysis of the tumor as a predictor of adverse outcome in patients with advanced-stage classical Hodgkin lymphoma treated with BEACOPP
    Jachimowicz, Ron Daniel
    Pieper, Luise
    Reinke, Sarah
    Gontarewicz, Artur
    Pluetschow, Annette
    Haverkamp, Heinz
    Frauenfeld, Leonie
    Fend, Falko
    Overkamp, Mathis
    Jochims, Franziska
    Thorns, Christoph
    Hansmann, Martin Leo
    Moller, Peter
    Rosenwald, Andreas
    Stein, Harald
    Reinhardt, Hans Christian
    Borchmann, Peter
    von Tresckow, Bastian
    Engert, Andreas
    Klapper, Wolfram
    HAEMATOLOGICA, 2021, 106 (06) : 1684 - 1692
  • [26] Body Composition Change, Unhealthy Lifestyles and Steroid Treatment as Predictor of Metabolic Risk in Non-Hodgkin's Lymphoma Survivors
    Daniele, A.
    Guarini, A.
    Summa, S. De
    Dellino, M.
    Lerario, G.
    Ciavarella, S.
    Ditonno, P.
    Paradiso, A. V.
    Divella, R.
    Casamassima, P.
    Savino, E.
    Carbonara, M. D.
    Minoia, C.
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (03):
  • [27] Baseline metabolic tumor volume calculation using different SUV thresholding methods in Hodgkin lymphoma patients: interobserver agreement and reproducibility across software platforms
    Tutino, Francesca
    Puccini, Giulia
    Linguanti, Flavia
    Puccini, Benedetta
    Rigacci, Luigi
    Kovalchuk, Sofya
    Sciagra, Roberto
    Berti, Valentina
    NUCLEAR MEDICINE COMMUNICATIONS, 2021, 42 (03) : 284 - 291
  • [28] Metabolic tumor volume and the survival of patients with Non-Hodgkin lymphoma treated with chimeric antigen receptor T cell therapy: a meta-analysis
    Liu, Lin
    Jin, Feng
    Fan, Hua
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [29] Mid-treatment Metabolic Tumor Volume Predicts Progression and Death among Patients with Hodgkin's Disease
    Tseng, D.
    Rachakonda, L. P.
    Su, Z.
    Advani, R.
    Horning, S.
    Rosenberg, S. A.
    Hoppe, R. T.
    Quon, A.
    Graves, E. E.
    Loo, B. W.
    Tran, P. T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S546 - S547
  • [30] Metabolic tumor volume by positron emission tomography/computed tomography as a clinical parameter to determine therapeutic modality for early stage Hodgkin's lymphoma
    Song, Moo-Kon
    Chung, Joo-Seop
    Lee, Je-Jung
    Jeong, Shin Young
    Lee, Sang-Min
    Hong, Jun-Shik
    Chong, Ari
    Moon, Joon-Ho
    Kim, Ji-Hyun
    Lee, Seok-Mo
    Kim, Seong Jang
    Shin, Ho-Jin
    CANCER SCIENCE, 2013, 104 (12) : 1656 - 1661
12345